Dedicated to bringing you top experts in the field, Biotech Banter promises a host of thought leaders and experienced professionals that can provide you with insight you might otherwise miss. The first episode features Dr. David Smith, Vice President of Development at BioCentriq, and Dr. Qasim Rafiq, an Associate Professor in Cell and Gene Therapy Bioprocess Engineering at University College London.
Together, they delved into some much-discussed topics circulating the industry today, including automation that streamlines production and the possibilities and benefits of “platformization.” They also shed light on the challenges faced by early-stage companies in transitioning into a commercialization structure and provided valuable insights into how the industry can support academia in developing groundbreaking processes and therapies that have the potential to save lives.
Click here to listen to the first episode now!
Subscribe and Connect!
With expert insights, tips, and information, Biotech Banter will help you discover what it takes to set the stage for successful clinical manufacturing, how to decide if working with a CDMO is the right move for your project, how to get the most out of your partnership with a CDMO, and more.
Don’t miss out on the opportunity to stay at the forefront of cell therapy advancements and to obtain expert opinions, tips, and lessons. Subscribe to Biotech Banter now to get alerted when the next episode is released! We’d also love to hear your thoughts, questions, or suggestions for additional episodes. Email us at imane.benbelkheir@biocentriq.com if you have anything to share with us.